United States Gonorrhea Therapeutics Market, By Infection (Uncomplicated Gonococcal Infection, Complicated Gonococcal Infection, Gonococcal Arthritis & Gonococcal Meningitis and Endocarditis), By Application (Clinics, Hospitals & Others), By Treatment (Monotherapy & Dual Therapy), By Route of administration (Oral & Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies & Others), United States Trend Analysis, Competitive Market Share & Forecast, 2021-2031
  1. Home
  2. Feature Reports
  3. Health Care
Published:
January 2021
Report Code:
BWC20267
Available Format:
PDF PDF Icon
Pages:
165

united states gonorrhea therapeutics market

1.      Research Framework

1.1.       Research Objective

1.2.       Product Overview

1.3.       Market Segmentation

2.      Research Methodology

2.1.       Qualitative Research

2.1.1.     Primary & Secondary Research

2.2.       Quantitative Research

2.3.       Market Breakdown & Data Triangulation

2.3.1.     Secondary Research

2.3.2.     Primary Research

2.4.       Breakdown of Primary Research Respondents, By Region

2.5.       Assumption &Limitation

3.      Executive Summary

4.      United States Gonorrhea Therapeutics Market Insights

4.1.       DROCAnalysis

4.1.1.     Growth Drivers

4.1.2.     Restraints

4.1.3.     Opportunities

4.1.4.     Challenges

4.2.       Recent Development

4.3.       Regulatory Framework

4.4.       Porter’s Five Forces Analysis

4.4.1.     Bargaining Power of Suppliers

4.4.2.     Bargaining Power ofBuyers

4.4.3.     Threat of NewEntrants

4.4.4.     Threat ofSubstitutes

4.4.5.     Intensity ofRivalry

4.5.       COVID-19 ImpactAnalysis

5.      United States Gonorrhea Therapeutics Market Overview

5.1.       Market Size & Forecast by Value,2016-2031

5.1.1.     By Value (USDMillion)

5.2.       Market Share &Forecast

5.2.1.                  By Gonococcal Infection

5.2.1.1.      Uncomplicated Gonococcal Infection

Additional Customization on Complicated Gonococcal Infection

 

5.2.1.2.      Complicated Gonococcal Infection –

5.2.1.3.      GonococcalArthritis

5.2.1.4.      Gonococcal Meningitis andEndocarditis

5.2.2.                  By Treatment

5.2.2.1.      Monotherapy

5.2.2.2.      DualTherapy

5.2.3.                  By Distribution Channel

5.2.3.1.      Hospital Pharmacies

5.2.3.2.      Retail Pharmacies

5.2.3.3.      Online Pharmacies

5.2.3.4.      Others

5.2.4.                  By Route of Administration

5.2.4.1.      Oral

5.2.4.2.      Injectable

5.2.5.                  By Application

5.2.5.1.      Clinics

5.2.5.2.      Hospitals

5.2.5.3.      Others

6.      Competitive Landscape

6.1.      List of Key Players and Their Offerings

6.2.      Market/Ranking Share Analysis

6.3.      Competitive Benchmarking, By Operating Parameters

7.      Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*

7.1.     GlaxoSmithKlineplc.

7.2.     Merck & Co.,Inc.

7.3.     PfizerInc

7.4.     AstraZeneca

7.5.     Hologic,Inc.

7.6.     Danaher

7.7.     Abbott

7.8.     Becton Dickinson andCompany

7.9.     F. Hoffmann-La RocheLtd.

7.10.    AlopexxPharmaceuticals

7.11.    MelintaTherapeutics

 

 

List of Figures

Fig: United States Gonorrhoea Therapeutics Segmentation

Fig: United States Gonorrhoea Therapeutics Market Value Chain Analysis

Fig: Company Market Share Analysis, 2019

Fig: United States Gonorrhoea Therapeutics Market Size, By Value (USD Million), 2016-2031

Fig: United States Gonorrhoea Therapeutics Market Share, By Distribution Channel, By Value, 2016-2031

Fig: United States Gonorrhoea Therapeutics Market Share, By Infection, By Value, 2016-2031

Fig: United States Gonorrhoea Therapeutics Market Share, By Application, By Value, 2016-2031

Fig: United States Gonorrhoea Therapeutics Market Share, By Treatment, By Value, 2016-2031

Fig: United States Gonorrhoea Therapeutics Market Share, By Route of administration, By Value, 2016-2031

 

 

 

List of Table

 

Table: United States Gonorrhoea Therapeutics Market Size, By Value (USD Million), 2016-2031

Table: United States Gonorrhoea Therapeutics Market Share, By Distribution Channel, By Value, 2016-2031

Table: United States Gonorrhoea Therapeutics Market Share, By Infection, By Value, 2016-2031

Table: United States Gonorrhoea Therapeutics Market Share, By Application, By Value, 2016-2031

Table: United States Gonorrhoea Therapeutics Market Share, By Treatment, By Value, 2016-2031

Table: United States Gonorrhoea Therapeutics Market Share, By Route of administration, By Value, 2016-2031

 

PLACE AN ORDER

 SINGLE USER LICENSE $4250
 GROUP LICENSE $5250
 ENTERPRISE LICENSE $6000
    PayPal
ENQUIRE BEFORE PURCHASE

RELATED REPORTS

WHY CHOOSE US

  • 24/7 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Coustom Research Service

    Ask the Analyst to customize an exclusive study to serve your research needs.

  • Quality & Accuracy

    offers best quality reports based on various authentic and accurate data findings.

  • Data Visualization

    As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization

  • Information security

    We never share your personal and confidential information. Your personal information is safe and secure with us.